PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 12494454-10 2003 We tested whether the RA-induced AP-1 activity might be mediated by the ERK1/2 MAPK pathway. Tretinoin 22-24 mitogen-activated protein kinase 3 Mus musculus 72-78 14603524-5 2004 We demonstrate that RA-induced differentiation of CCE ES cells is associated with (1) downregulation of the LIF receptor (LIFR); (2) decreased tyrosine phosphorylation of signal transducer and activator of transcription 3 protein (Stat3); and (3) increased activation of extracellular regulated kinase (Erk1/2). Tretinoin 20-22 mitogen-activated protein kinase 3 Mus musculus 303-309 26108692-1 2015 We recently identified that the MEK/ERK1/2 pathway synergized with retinoic acid (RA) to restore both transcriptional activity and RA-induced differentiation in RA-resistant acute promyelocytic leukemia (APL) cells. Tretinoin 67-80 mitogen-activated protein kinase 3 Mus musculus 36-42 31682623-0 2019 Retinoic acid-stimulated ERK1/2 pathway regulates meiotic initiation in cultured fetal germ cells. Tretinoin 0-13 mitogen-activated protein kinase 3 Mus musculus 25-31 31682623-4 2019 When XX germ cells at embryonic day (E) 12.5 were cultured with RA, the extracellular-signal-regulated kinase (ERK) 1/2 pathway was predominantly activated. Tretinoin 64-66 mitogen-activated protein kinase 3 Mus musculus 72-119 31682623-7 2019 Taken together, our results suggest the novel concept that the RA functions by stimulating the ERK1/2 pathway and that this activity is critical for Stra8 expression and meiotic progression in fetal germ cells. Tretinoin 63-65 mitogen-activated protein kinase 3 Mus musculus 95-101 31035455-2 2019 In F9 embryonic carcinoma cells, RA can induce differentiation towards somatic lineages via the Ras-extracellular signal-regulated kinase (Ras/Erk) pathway, but the mechanism through which it induces the Erk1/2 phosphorylation is unclear. Tretinoin 33-35 mitogen-activated protein kinase 3 Mus musculus 204-210 31035455-6 2019 In summary, RA can mediate cell differentiation by phosphorylating Erk1/2 via miR-485 and Abhd2. Tretinoin 12-14 mitogen-activated protein kinase 3 Mus musculus 67-73 26108692-1 2015 We recently identified that the MEK/ERK1/2 pathway synergized with retinoic acid (RA) to restore both transcriptional activity and RA-induced differentiation in RA-resistant acute promyelocytic leukemia (APL) cells. Tretinoin 82-84 mitogen-activated protein kinase 3 Mus musculus 36-42 26108692-1 2015 We recently identified that the MEK/ERK1/2 pathway synergized with retinoic acid (RA) to restore both transcriptional activity and RA-induced differentiation in RA-resistant acute promyelocytic leukemia (APL) cells. Tretinoin 131-133 mitogen-activated protein kinase 3 Mus musculus 36-42 23530929-6 2013 In addition, RA-induced inhibition of gamma-secretase activity was found to be mediated through significant activation of extracellular signal-regulated kinases (ERK1/2). Tretinoin 13-15 mitogen-activated protein kinase 3 Mus musculus 162-168 26208884-5 2015 Most interestingly, TLR ligation in the presence of recombinant IL-10 (rIL-10) or retinoic acid (RA) led to ERK1/2 activation independent of MEK1 in BMDMs derived from Mek1(d/d)Sox2(Cre) mice and led to inhibition of STAT4 and decreased IL-12 levels. Tretinoin 82-95 mitogen-activated protein kinase 3 Mus musculus 108-114 24440820-6 2014 We demonstrate that during neuronal differentiation of Neuro-2a cells, RA induces Chka expression by a mechanism that involves ERK1/2 activation which triggers C/EBPbeta expression. Tretinoin 71-73 mitogen-activated protein kinase 3 Mus musculus 127-133 21931768-7 2011 Conversely, atRA markedly increased ERK1/2 activation, and blockade of ERK1/2 signaling completely abolished the enhanced effects of atRA on Foxp3 expression. Tretinoin 12-16 mitogen-activated protein kinase 3 Mus musculus 36-42 21931768-7 2011 Conversely, atRA markedly increased ERK1/2 activation, and blockade of ERK1/2 signaling completely abolished the enhanced effects of atRA on Foxp3 expression. Tretinoin 133-137 mitogen-activated protein kinase 3 Mus musculus 71-77 17712061-4 2008 atRA (10 nM) increased ERK1/2 phosphorylation within 10 min. Tretinoin 0-4 mitogen-activated protein kinase 3 Mus musculus 23-29 17026715-5 2006 Western blot analysis showed a dramatic increase in ERK 1/2 phosphorylation (p-ERK 1/2) 1-5 days after RA induction, which was attenuated in the presence of the p-ERK 1/2-specific inhibitor UO126. Tretinoin 103-105 mitogen-activated protein kinase 3 Mus musculus 52-59 17026715-5 2006 Western blot analysis showed a dramatic increase in ERK 1/2 phosphorylation (p-ERK 1/2) 1-5 days after RA induction, which was attenuated in the presence of the p-ERK 1/2-specific inhibitor UO126. Tretinoin 103-105 mitogen-activated protein kinase 3 Mus musculus 79-86 17026715-5 2006 Western blot analysis showed a dramatic increase in ERK 1/2 phosphorylation (p-ERK 1/2) 1-5 days after RA induction, which was attenuated in the presence of the p-ERK 1/2-specific inhibitor UO126. Tretinoin 103-105 mitogen-activated protein kinase 3 Mus musculus 52-57